FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice

Chronic kidney disease (CKD) is a worldwide health problem. Serum levels of FGF23, a phosphaturic hormone, increase at the earliest stages of CKD, and have been found to be independently associated with the mortality and morbidity of CKD patients. The purpose of this study was to evaluate whether FG...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ningyuan, Guo, Yuchen, Liu, Weiqing, Densmore, Michael, Shalhoub, Victoria, Erben, Reinhold G., Ye, Ling, Lanske, Beate, Yuan, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322353/
https://www.ncbi.nlm.nih.gov/pubmed/25665715
http://dx.doi.org/10.1038/srep08304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322353/
https://www.ncbi.nlm.nih.gov/pubmed/25665715
http://dx.doi.org/10.1038/srep08304

Ejemplares similares